N-Zyme Biomedical

N-Zyme Biomedical

N-Zyme Biomedical

  • N-Zyme Biomedical just raised $4.6M (Series A) on Jul 21

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.

2021Active5Newark, United States

About

N-Zyme Biomedical is a clinical-stage biotechnology company developing first-in-class therapies that target pepsin, a key driver of tissue damage in reflux disease. The company's lead drug candidate, NZ-101, is currently in Phase 2 clinical trials for laryngopharyngeal reflux (LPR) and proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD). N-Zyme Biomedical aims to transform the treatment of reflux disease by addressing its underlying causes rather than solely focusing on acid suppression.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to N-Zyme Biomedical?

People comparing tools land here. Get listed beside these.

All funding rounds

Key facts

Website
nzymebio.com
Headquarters
Newark, United States
Founded
2021
Employees
5
Total funding
$5M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by N-Zyme Biomedical
DateRoundAmountLead investors
21 Jul 2026Series A$5M

Tech stack

Detected on nzymebio.com, last scanned 15 Nov 2026.

Analytics
Hotjar
CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Google Workspace
Video / media
YouTube

Benchmarking

See how your site ranks against 16,849 startups

N-Zyme Biomedical sits in the 12th percentile for Domain Rating. Check where yours lands, free.

Check your Domain Rating

N-Zyme Biomedical has a Domain Rating of 7, the 12th percentile of 16,849 startups we track.

Scores

Measured, not editorial

7

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Bottom 25%

Check yours
43

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Above median

Scan yours
61

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Below median

PageSpeed
66

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Above median

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

N-Zyme Biomedical scores 43. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

AI visibility

Get read by ChatGPT, Claude and Perplexity

List your startup, then track where you show up in AI answers.

AI reads of this profile

Last 14 days, from server logs

Get notified when N-Zyme Biomedical changes

Used N-Zyme Biomedical? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Is N-Zyme Biomedical growing?

Yes, fast. Our data shows it raised $4.6M in a Series A in July 2026.

Are there companies like N-Zyme Biomedical?

Yes. We list 6 companies like N-Zyme Biomedical, including Moderna, Degron Therapeutics and Epicrispr Biotechnologies.

Is N-Zyme Biomedical trustworthy and reputable?

StartupHub's Data Trust & Reputation score for N-Zyme Biomedical is 66 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has N-Zyme Biomedical raised?

N-Zyme Biomedical has raised a total of $5M in funding. The most recent round on record is Series A.

How many employees does N-Zyme Biomedical have?

N-Zyme Biomedical has approximately 5 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for N-Zyme Biomedical:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch N-Zyme Biomedical and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini